NTRB (Nutriband) Interest Expense (Positive)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NTRB Nutriband Inc NTRB
57 GF Score
Price $4.67
GF Value $3.20
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Nutriband Interest Expense (Positive)?

Interest Expense (Positive) only applies to insurance companies.

NTRB
57GF Score
Nutriband Inc NTRB
Interest Expense (Positive) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nutriband (NTRB) Overvalued in 2026?

Based on GuruFocus' analysis, Nutriband stock appears to be overvalued. The current stock price of $4.67 is trading 45.8% above its estimated GF Value™ of $3.20. GuruFocus considers Nutriband to be Significantly Overvalued.

Key valuation signals for NTRB:

  • Interest Expense (Positive):
  • GF Value™: $3.20 vs. price of $4.67 (45.8% above fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the NTRB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nutriband Business Description

Other Exchanges 9WV:Germany
Address 121 South Orange Avenue, Suite 1500, Orlando, FL, USA, 32801
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
57GF Score

Get the complete analysis for NTRB

Interest Expense (Positive) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.67
Price
$3.20
GF Value